Paper Details

  1. Home
  2. Paper Details

Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.

Author: BellaceDara, CarinoJanel, DevlinMichael J, DobrowIlyse, GoldfeinJuli A, JiangHuiping, KamenetzClaudia, MayerLaurel, PetkovaEva, RaizmanPamela S, WalshB Timothy, WolkSara

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

This study investigates the added benefit of individual cognitive behavioral therapy (CBT) and fluoxetine, offered alongside group behavioral weight control treatment, for individuals with binge eating disorder and obesity.
Paper Details　
Original Abstract of the Article :
Although binge eating disorder is a common and distressing concomitant of obesity, it has not yet been established whether affected individuals presenting to behavioral weight control programs should receive specialized treatments to supplement standard treatment. This study was designed to examine ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1038/oby.2005.126

データ提供：米国国立医学図書館（NLM）

Cognitive Behavioral Therapy and Fluoxetine as Adjuncts to Group Behavioral Therapy for Binge Eating Disorder

Binge eating disorder (BED) is like a relentless sandstorm that can sweep through a person's life, leaving a trail of emotional distress and physical consequences. This study, a beacon of hope in the vast desert of BED research, investigated the effectiveness of two adjunctive interventions, individual cognitive behavioral therapy (CBT) and fluoxetine, as supplements to group behavioral weight control treatment. The researchers, like skilled desert navigators, sought to determine whether these interventions could help individuals struggling with BED find a path towards recovery. The results suggested that both CBT and fluoxetine may have a positive impact, potentially offering a more comprehensive approach to managing BED.

CBT and Fluoxetine: A Multifaceted Approach to BED

The study suggests that CBT and fluoxetine, when combined with group behavioral weight control, may provide a more comprehensive approach to managing BED. This multifaceted approach, like a carefully constructed oasis in a vast desert, could offer individuals with BED a place of solace and support.

Hope for BED Management

The findings of this study offer hope for individuals struggling with BED. The combination of CBT and fluoxetine may provide a powerful tool for managing this challenging eating disorder, potentially leading to a more fulfilling and healthier life.

Dr.Camel's Conclusion

This study is like a refreshing oasis in the vast desert of BED research. The findings suggest that combining CBT and fluoxetine with group behavioral weight control may provide a more effective approach to managing BED. This approach, like a carefully curated desert garden, offers a promising avenue for individuals seeking to overcome the challenges of BED and reclaim their well-being.

Date :
  1. Date Completed 2005-10-20
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

15976151

DOI: Digital Object Identifier

10.1038/oby.2005.126

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.